Allspring Global Investments’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Allspring Global Investments's HAE Position: Q2 2026 in Review
Allspring Global Investments reduced its Haemonetics (HAE) stake by 14% in Q2 2026, selling an estimated $8.04M and leaving 765,120 shares worth $57.3M. The position accounts for 0.09% of the portfolio, ranked #257.
Allspring Global Investments first reported a position in HAE in Q4 2021 and has held it in 19 quarters since. The position peaked at $75.2M in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Allspring Global Investments held 765,120 shares of Haemonetics worth $57.3M as of Q2 2026.
- Allspring Global Investments sold 125,104 Haemonetics shares in Q2 2026, an estimated $8.04M.
- Haemonetics made up 0.09% of Allspring Global Investments's portfolio in Q2 2026, its #257 holding.
- Allspring Global Investments first reported a position in Haemonetics in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's Haemonetics position peaked at $75.2M in Q4 2025.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.